The Menopausal Transition
Interface between Gynecology and PsychiatryEditor(s): Soares C.N. (Hamilton, Ont.)
Warren M. (New York, N.Y.)
Psychotic Disorders and Menopause: The Untold StoryRiecher-Rössler A.
Psychiatric Outpatient Department, University Hospital Basel, Basel, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
This chapter aims to give an overview on the influence of menopause on psychotic disorders.Menopause is associated with a loss of estrogens; estrogen has important neuro- and psychoprotec-tive activities, thus its decline and/or instability may trigger or aggravate mental disorders includingpsychotic ones. As a result, perimenopause may lead to an enhanced risk of first onset of schizophrenic psychoses or ‘late-onset schizophrenia’. Women with pre-existing chronic schizophreniatend to have a deterioration of their illness after menopause and a higher demand for antipsychoticmedication. Apart from the psychotic symptoms, many other conditions can be aggravated by theloss of estrogens, including sleep disturbances, irritability, depression, cognitive impairment andsexual problems. In addition, many females with diagnosis of schizophrenia may present with premature menopause due to antipsychotic or stress-induced hyperprolactinamia and the subsequentgonadal suppression. Apart from psychotherapy and social measures, replacement of 17β-estradiolmay be helpful in women with schizophrenia in the perimenopause and early postmenopause, butits use might also carry some risks. More research is needed on the indications and contraindicationsfor hormone replacement in this context.
© 2009 S. Karger AG, Basel
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.